Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/14238
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVan Heirstraeten, Liesbet-
dc.contributor.authorCoenen, Samuel-
dc.contributor.authorLammens, Christine-
dc.contributor.authorHENS, Niel-
dc.contributor.authorGoossens, Herman-
dc.contributor.authorMalhotra-Kumar, Surbhi-
dc.date.accessioned2012-10-05T09:13:44Z-
dc.date.available2012-10-05T09:13:44Z-
dc.date.issued2012-
dc.identifier.citationEMERGING INFECTIOUS DISEASES, 18 (9), p. 1515-1518-
dc.identifier.issn1080-6040-
dc.identifier.urihttp://hdl.handle.net/1942/14238-
dc.description.abstractIn Belgium, decreasing macrolide, lincosamide, streptogramins B, and tetracycline use during 1997-2007 correlated significantly with decreasing macrolide-resistant Streptococcus pyogenes during 1999-2009. Maintaining drug use below a critical threshold corresponded with low-level macrolide-resistant S. pyogenes and an increased number of erm(A)-harboring emm77 S. pyogenes with low fitness costs.-
dc.description.sponsorshipThis study was partly funded by the Belgian Antibiotic Policy Coordination Committee.-
dc.language.isoen-
dc.publisherCENTERS DISEASE CONTROL-
dc.subject.otherImmunology; Infectious Diseases-
dc.titleAntimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium-
dc.typeJournal Contribution-
dc.identifier.epage1518-
dc.identifier.issue9-
dc.identifier.spage1515-
dc.identifier.volume18-
local.format.pages4-
local.bibliographicCitation.jcatA1-
dc.description.notesMalhotra-Kumar, S (reprint author),[Van Heirstraeten, Liesbet; Coenen, Samuel; Lammens, Christine; Hens, Niel; Goossens, Herman; Malhotra-Kumar, Surbhi] Univ Antwerp, B-2020 Antwerp, Belgium. [Hens, Niel] Univ Hasselt, Hasselt, Belgium. surbhi.malhotra@ua.ac.be-
local.publisher.placeATLANTA-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.bibliographicCitation.oldjcatA1-
dc.identifier.doi10.3201/eid1809.120049-
dc.identifier.isi000307989700024-
item.fulltextWith Fulltext-
item.contributorVan Heirstraeten, Liesbet-
item.contributorCoenen, Samuel-
item.contributorLammens, Christine-
item.contributorHENS, Niel-
item.contributorGoossens, Herman-
item.contributorMalhotra-Kumar, Surbhi-
item.fullcitationVan Heirstraeten, Liesbet; Coenen, Samuel; Lammens, Christine; HENS, Niel; Goossens, Herman & Malhotra-Kumar, Surbhi (2012) Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium. In: EMERGING INFECTIOUS DISEASES, 18 (9), p. 1515-1518.-
item.accessRightsOpen Access-
item.validationecoom 2013-
crisitem.journal.issn1080-6040-
crisitem.journal.eissn1080-6059-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Antimicrobial drug use and macrolide-resistant streptococcus pyogenes, Belgium.pdfPublished version312.48 kBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.